Clinical Trial Update: What is the Best Interval to Screen Women 45-49 and 70-74 for Breast Cancer? [NA]

View source ↗

Summary

This clinical trial update details a study sponsored by Istituto Romagnolo per lo Studio dei Tumatori Dino Amadori IRST S.r.l. IRCCS investigating the best inte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Conditions: Breast Cancer | NA | Status: RECRUITING